{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:52:37Z","timestamp":1788997957172,"version":"build-2803163510"},"reference-count":56,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["22K08379"],"award-info":[{"award-number":["22K08379"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>There are comorbidities and complications in atopic dermatitis and psoriasis that often occur after the appearance of skin inflammation. Statistically, data show that patients with psoriasis and atopic dermatitis have a shorter life expectancy than patients without psoriatic dermatitis, due to the occurrence of arteriosclerosis, myocardial infarction, and cerebral infarction. Many types of skin inflammation are treated with various antibody preparations, and marked improvement in patients\u2019 quality of life can be achieved. The next theme is to understand the pathogenesis of arteriosclerosis, myocardial infarction, stroke, and other complications associated with dermatitis and to find treatments and drugs to reduce their occurrence. The skin, a crucial immune organ, generates large amounts of inflammatory cytokines in response to various stimuli, leading to systemic inflammation and potential damage to internal organs. The link between inflammatory skin conditions like psoriasis and atopic dermatitis with serious health complications such as vascular disorders and systemic amyloidosis has been increasingly recognized. In psoriasis, biological treatments targeting Interleukin (IL)-17A, a key cytokine, have shown promise in reducing cardiovascular risks. Recent developments include treatments that target both IL-17A and IL-17F in the psoriasis field, though each cytokine\u2019s impact on internal organ damage is still under debate. Among visceral complications secondary to dermatitis, systemic amyloidosis and atherosclerosis have been reported to be controlled by suppressing IL-17 in the early stages of dermatitis. Still, it remains unclear whether suppressing IL-17 prevents organ damage in the late stages of persistent severe dermatitis. A study using a long-lasting dermatitis mouse model that overexpressed human caspase-1 in keratinocytes (Kcasp1Tg) investigated the effects of deleting IL-17A and IL-17F on visceral complications. Cross-mating Kcasp1Tg with IL-17A-, IL-17F-, and IL-17AF-deficient mice assessed the skin and visceral organs histologically, and RT-PCR analysis of aortic sclerosis markers was performed. Despite less improvement in dermatitis, deletion of IL-17A in Kcasp1Tg mice showed promising results in reducing multiple organ amyloidosis. On the other hand, the effect was observed in both IL-17A and IL-17F deleted mice for aortic sclerosis. The inhibition of IL-17A and IL-17F was suggested to reduce the risk of developing comorbidities in internal organs. IL-17A and IL-17F were found to act similarly or produce very different results, depending on the organ.<\/jats:p>","DOI":"10.3390\/ijms252111617","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T08:42:09Z","timestamp":1730191329000},"page":"11617","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Amelioration of Systemic Amyloidosis by Blocking IL-17A and Not by IL-17F, and Arteriosclerosis by Blocking Both IL-17A and IL-17F in an Inflammatory Skin Mouse Model"],"prefix":"10.3390","volume":"25","author":[{"given":"Takehisa","family":"Nakanishi","sequence":"first","affiliation":[{"name":"Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Iida","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Ichishi","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1560-6067","authenticated-orcid":false,"given":"Makoto","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6114-0830","authenticated-orcid":false,"given":"Yoshiaki","family":"Matsushima","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9934-5775","authenticated-orcid":false,"given":"Yoichiro","family":"Iwakura","sequence":"additional","affiliation":[{"name":"Center for Animal Disease Models, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba 278-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","article-title":"Cause-specific mortality in patients with severe psoriasis: A population-based cohort study in the U.K","volume":"163","author":"Abuabara","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/archdermatol.2012.2502","article-title":"Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis","volume":"148","author":"Wu","year":"2012","journal-title":"Arch. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/77811","article-title":"IL-18 induction of IgE: Dependence on CD4+ T cells, IL-4 and STAT6","volume":"1","author":"Yoshimoto","year":"2000","journal-title":"Nat. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"11340","DOI":"10.1073\/pnas.152337799","article-title":"IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE\/stat6 under specific pathogen-free conditions","volume":"99","author":"Konishi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jid.2018.04.016","article-title":"The Stenosis of Cerebral Arteries and Impaired Brain Glucose Uptake by Long-Lasting Inflammatory Cytokine Release from Dermatitis Is Rescued by Anti-IL-1 Therapy","volume":"138","author":"Kato","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e104479","DOI":"10.1371\/journal.pone.0104479","article-title":"Persistent Release of IL-1s from Skin Is Associated with Systemic Cardio-Vascular Disease, Emaciation and Systemic Amyloidosis: The Potential of Anti-IL-1 Therapy for Systemic Inflammatory Diseases","volume":"9","author":"Yamanaka","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Nakanishi, T., Mizutani, K., Iida, S., Matsushima, Y., Umaoka, A., Kondo, M., Habe, K., and Yamanaka, K. (2021). Janus Kinase Inhibitors Ameliorated Gastrointestinal Amyloidosis and Hypoalbuminemia in Persistent Dermatitis Mouse Model. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010028"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Iida, S., Nakanishi, T., Momose, F., Ichishi, M., Mizutani, K., Matsushima, Y., Umaoka, A., Kondo, M., Habe, K., and Hirokawa, Y. (2022). IL-17A Is the Critical Cytokine for Liver and Spleen Amyloidosis in Inflammatory Skin Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105726"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Umaoka, A., Takeuchi, H., Mizutani, K., Seo, N., Matsushima, Y., Habe, K., Hagimori, K., Yamaguchi, Y., Ikeda, T., and Yamanaka, K. (2020). Skin Inflammation and Testicular Function: Dermatitis Causes Male Infertility via Skin-Derived Cytokines. Biomedicines, 8.","DOI":"10.3390\/biomedicines8090293"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Mizutani, K., Isono, K., Matsushima, Y., Okada, K., Umaoka, A., Iida, S., Habe, K., Hagimori, K., Yamazaki, H., and Yamanaka, K. (2020). Inflammatory Skin-Derived Cytokines Accelerate Osteoporosis in Mice with Persistent Skin Inflammation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103620"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Iida, S., Shoji, H., Kawakita, F., Nakanishi, T., Matsushima, Y., Kondo, M., Habe, K., Suzuki, H., Miyakawa, T., and Yamanaka, K. (2023). Inflammatory Skin Disease Causes Anxiety Symptoms Leading to an Irreversible Course. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065942"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Nishimura, M., Nakanishi, T., Ichishi, M., Matsushima, Y., Watanabe, M., and Yamanaka, K. (2024). Increased Mortality Risk at Septic Condition in Inflammatory Skin Disorders and the Effect of High-Fat Diet Consumption. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010478"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mizutani, K., Shirakami, E., Ichishi, M., Matsushima, Y., Umaoka, A., Okada, K., Yamaguchi, Y., Watanabe, M., Morita, E., and Yamanaka, K. (2020). Systemic Dermatitis Model Mice Exhibit Atrophy of Visceral Adipose Tissue and Increase Stromal Cells via Skin-Derived Inflammatory Cytokines. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093367"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: Potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_15","first-page":"677","article-title":"The risk of cardiomyopathy in inherited epidermolysis bullosa","volume":"159","author":"Fine","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","article-title":"Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986\u2013006","volume":"60","author":"Fine","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jaci.2015.06.009","article-title":"\u201cInflammatory skin march\u201d: IL-1-mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events","volume":"136","author":"Yamanaka","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"100504","DOI":"10.1016\/j.xkme.2022.100504","article-title":"Serum Amyloid A Protein-Associated Kidney Disease: Presentation, Diagnosis, and Management","volume":"4","author":"Thorne","year":"2022","journal-title":"Kidney Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"151943","DOI":"10.1016\/j.semarthrit.2021.12.011","article-title":"Association between serum amyloid A and rheumatoid arthritis: A systematic review and meta-analysis","volume":"52","author":"Zhou","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.rdc.2018.06.004","article-title":"Amyloidosis","volume":"44","author":"Papa","year":"2018","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/07853890.2016.1195011","article-title":"Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases","volume":"48","author":"Colia","year":"2016","journal-title":"Ann. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/MEG.0000000000002649","article-title":"Therapeutic effects of biological treatments on AA amyloidosis associated with inflammatory bowel disease: A case report and literature review","volume":"35","author":"Alhalabi","year":"2023","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/ibd\/izac140","article-title":"Renal and Urological Disorders Associated With Inflammatory Bowel Disease","volume":"29","author":"Kumar","year":"2023","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/ecco-jcc\/jjw080","article-title":"Amyloidosis in Inflammatory Bowel Disease: A Systematic Review of Epidemiology, Clinical Features, and Treatment","volume":"10","year":"2016","journal-title":"J. Crohns. Colitis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2169\/internalmedicine.52.0340","article-title":"Successful use of maintenance infliximab for nephropathy in a patient with secondary amyloidosis complicating Crohn\u2019s disease","volume":"52","author":"Tada","year":"2013","journal-title":"Intern. Med."},{"key":"ref_26","first-page":"369","article-title":"Systemic AA amyloidosis: Epidemiology, diagnosis, and management","volume":"6","author":"Costa","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/14397595.2018.1515145","article-title":"AA amyloidosis\u2014Benefits and prospects of IL-6 inhibitors","volume":"29","author":"Okuda","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/1346-8138.14665","article-title":"Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T-cell lymphoma","volume":"45","author":"Suzuki","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jid.2018.10.042","article-title":"Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks","volume":"139","author":"Reich","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/exd.14452","article-title":"TNF-alpha blockade may lead to improvement of vascular function in psoriasis patients","volume":"31","author":"Wegner","year":"2022","journal-title":"Exp. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Nakanishi, T., Iida, S., Maruyama, J., Urushima, H., Ichishi, M., Matsushima, Y., Mizutani, K., Nakayama, Y., Sugioka, K., and Nishimura, M. (2023). Arteriosclerosis Derived from Cutaneous Inflammation Is Ameliorated by the Deletion of IL-17A and IL-17F. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065434"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/1744666X.2021.1967748","article-title":"Bimekizumab: A dual IL-17A and IL-17F inhibitor for the treatment of psoriasis and psoriatic arthritis","volume":"17","author":"Ali","year":"2021","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s40265-021-01612-z","article-title":"Bimekizumab for the Treatment of Psoriasis","volume":"81","author":"Freitas","year":"2021","journal-title":"Drugs"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"103529","DOI":"10.1016\/j.autrev.2024.103529","article-title":"Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation","volume":"23","author":"Robert","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1191782","DOI":"10.3389\/fimmu.2023.1191782","article-title":"The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases","volume":"14","author":"Puig","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11926-022-01084-4","article-title":"Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms","volume":"24","author":"Tam","year":"2022","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4049\/jimmunol.165.2.997","article-title":"Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18","volume":"165","author":"Yamanaka","year":"2000","journal-title":"J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3389\/fimmu.2018.01682","article-title":"The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond","volume":"9","author":"Brembilla","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Sanchez-Rodriguez, G., and Puig, L. (2023). Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241210305"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.4049\/jimmunol.174.12.8125","article-title":"Serum amyloid A-luciferase transgenic mice: Response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition","volume":"174","author":"Zhang","year":"2005","journal-title":"J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1432-1327.1999.00657.x","article-title":"Serum amyloid A, the major vertebrate acute-phase reactant","volume":"265","author":"Uhlar","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10875-009-9278-8","article-title":"Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases","volume":"29","author":"McNutt","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaci.2016.01.015","article-title":"Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis","volume":"138","author":"Andersen","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.jaci.2018.11.030","article-title":"Atopic eczema and major cardiovascular outcomes: A systematic review and meta-analysis of population-based studies","volume":"143","author":"Ascott","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Hu, S.C., and Lan, C.E. (2017). Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102211"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/jid.2009.112","article-title":"The risk of stroke in patients with psoriasis","volume":"129","author":"Gelfand","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00018-006-6091-x","article-title":"The function of apolipoproteins L","volume":"63","author":"Vanhollebeke","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/eji.201546252","article-title":"Apolipoproteins L control cell death triggered by TLR3\/TRIF signaling in dendritic cells","volume":"46","author":"Uzureau","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.032069099","article-title":"Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22","volume":"99","author":"Mimmack","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cellimm.2012.11.009","article-title":"A comprehensive summary of LL-37, the factotum human cathelicidin peptide","volume":"280","author":"Vandamme","year":"2012","journal-title":"Cell Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1073\/pnas.95.16.9541","article-title":"The peptide antibiotic LL-37\/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface","volume":"95","author":"Bals","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1189\/jlb.0403147","article-title":"Cathelicidins, multifunctional peptides of the innate immunity","volume":"75","author":"Zanetti","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ni.3023","article-title":"Chitinase-like proteins promote IL-17-mediated neutrophilia in a tradeoff between nematode killing and host damage","volume":"15","author":"Sutherland","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/hsz-2015-0269","article-title":"Role of chitinase-like proteins in cancer","volume":"397","author":"Kzhyshkowska","year":"2016","journal-title":"Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","article-title":"S100A8\/A9 in Inflammation","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1074-7613(02)00391-6","article-title":"Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses","volume":"17","author":"Nakae","year":"2002","journal-title":"Immunity"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/21\/11617\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:23:07Z","timestamp":1760113387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/21\/11617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":56,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ijms252111617"],"URL":"https:\/\/doi.org\/10.3390\/ijms252111617","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]}}}